America August 25, 2025
AbbVie to Acquire Gilgamesh’s Bretisilocin in $1.2B Psychedelic Bet
AbbVie Inc., advised by Covington & Burling LLP, has announced a blockbuster acquisition of Gilgamesh Pharmaceuticals’ lead psychedelic therapy candidate,…
America August 25, 2025
AbbVie Inc., advised by Covington & Burling LLP, has announced a blockbuster acquisition of Gilgamesh Pharmaceuticals’ lead psychedelic therapy candidate,…
By Rihem Akkouche